SCHEMBL5439686

SCHEMBL5439686

COc1ccc(CCc2nnc(NC(=O)Nc3cccc(Cl)c3)s2)cc1OC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.60
KMT2A Q03164 6/20 0.60
RAB9A P51151 3/20 0.60
NPC1 O15118 3/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
SMN1; SMN2 Q16637 4/20 0.57
MAPT P10636 3/20 0.57
USP2 O75604 1/20 0.57
LMNA P02545 4/20 0.56
HTT P42858 4/20 0.56
GAA P10253 2/20 0.56
HPN P05981 1/20 0.56
GLS O94925 2/20 0.56
CCNC P24863 1/20 0.54
CDK8 P49336 1/20 0.54
POLB P06746 2/20 0.53
PAX8 Q06710 2/20 0.53
KDM4E B2RXH2 1/20 0.53
HPGD P15428 1/20 0.53
MCL1 Q07820 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5450985 0.91 KMT2A (0.72) MEN1KMT2ARAB9ANPC1L3MBTL1
SCHEMBL5443047 0.89 KMT2A (0.66) MEN1KMT2ARAB9ANPC1L3MBTL1
SCHEMBL5448515 0.86 MEN1 (0.59) MEN1KMT2ARAB9ANPC1L3MBTL1
SCHEMBL5439630 0.86 MEN1 (0.64) MEN1KMT2ARAB9ANPC1L3MBTL1
SCHEMBL5439879 0.85 NPC1 (0.57) MEN1KMT2ARAB9ANPC1L3MBTL1
SCHEMBL5444273 0.84 HPN (0.76) MEN1KMT2ARAB9ANPC1L3MBTL1
SCHEMBL3466663 0.83 KMT2A (0.69) MEN1KMT2ARAB9ANPC1L3MBTL1
SCHEMBL5446284 0.83 MEN1 (0.59) MEN1KMT2ARAB9ANPC1L3MBTL1
SCHEMBL5439656 0.81 MEN1 (0.62) MEN1KMT2ARAB9ANPC1L3MBTL1
SCHEMBL5441175 0.81 KMT2A (0.61) MEN1KMT2ARAB9ANPC1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070191353-A1 Use of thiadiazoleurea derivatives MERCK PATENT GMBH (DE) 2007-08-16 US claimed
US-20070191353-A1 Use of thiadiazoleurea derivatives MERCK PATENT GMBH (DE) 2007-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191353-A1 Use of thiadiazoleurea derivatives RAF1, ARAF, JAK1 MEN1 1756/4885KMT2A 1865/4885RAB9A 1942/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.